Population-adjusted indirect treatment comparison of maintenance PARP inhibitor with or without bevacizumab versus bevacizumab alone in women with newly diagnosed advanced ovarian...

por Hettle, Robert, McCrea, Charles, Lee, Chee Khoon, Davidson, Richard
Publicado 2021

When is a GIST not a GIST? A case report of synchronous metastatic gastrointestinal stromal tumor and fibromatosis

por Lee, Chee Khoon, Hadley, Alison, Desilva, Keshani, Smith, Gareth, Goldstein, David
Publicado 2009

Extrapolating evidence for molecularly targeted therapies from common to rare cancers: a scoping review of methodological guidance

por Cho, Doah, Cheyne, Saskia, Lord, Sarah J, Simes, John, Lee, Chee Khoon
Publicado 2022

When do patient reported quality of life indicators become prognostic in breast cancer?

por Lee, Chee Khoon, Hudson, Malcolm, Simes, John, Ribi, Karin, Bernhard, Jürg, Coates, Alan S.
Publicado 2018

Next-generation sequencing, should I use anti-HER2 therapy for HER2-amplified tumors off-label? Illustrating an extrapolation framework

por Cho, Doah, Lord, Sarah J., Simes, John, Cooper, Wendy, Friedlander, Michael, Bae, Susie, Lee, Chee Khoon
Publicado 2022

Progression-free survival as a surrogate endpoint for overall survival in modern ovarian cancer trials: a meta-analysis

por Sjoquist, Katrin M., Lord, Sarah J., Friedlander, Michael L., John Simes, Robert, Marschner, Ian C., Lee, Chee Khoon
Publicado 2018

Validation of Progression-Free Survival Rate at 6 Months and Objective Response for Estimating Overall Survival in Immune Checkpoint Inhibitor Trials: A Systematic Review and Meta-...

por Kok, Peey-Sei, Cho, Doah, Yoon, Won-Hee, Ritchie, Georgia, Marschner, Ian, Lord, Sally, Friedlander, Michael, Simes, John, Lee, Chee Khoon
Publicado 2020

Criteria-based curation of a therapy-focused compendium to support treatment recommendations in precision oncology

por Lin, Frank P., Thavaneswaran, Subotheni, Grady, John P., Ballinger, Mandy, Kansara, Maya, Oakes, Samantha R., Desai, Jayesh, Lee, Chee Khoon, Simes, John, Thomas, David M.
Publicado 2021

Trade-offs in quality of life and survival with chemotherapy for advanced breast cancer: mature results of a randomized trial comparing single-agent mitoxantrone with combination c...

por Lee, Chee Khoon, Gebski, Val J, Coates, Alan S, Veillard, Anne-Sophie, Harvey, Vernon, Tattersall, Martin HN, Byrne, Michael J, Brigham, Brian, Forbes, John, Simes, R John
Publicado 2013

Management Paradigm of Central Nervous System Metastases in NSCLC: An Australian Perspective

por Lee, Chee Khoon, Soon, Yu Yang, Jeffree, Rosalind L., Joshi, Rohit, Koh, Eng-Siew, Lam, Wei-Sen, Le, Hien, Lwin, Zarnie, Pinkham, Mark B., Siva, Shankar, Ng, Evan, John, Thomas
Publicado 2023

Pathways to diagnosis of non-small cell lung cancer: a descriptive cohort study

por Purdie, Stuart, Creighton, Nicola, White, Kahren Maree, Baker, Deborah, Ewald, Dan, Lee, Chee Khoon, Lyon, Alison, Man, Johnathan, Michail, David, Miller, Alexis Andrew, Tan, Lawrence, Currow, David, Young, Jane M.
Publicado 2019

Phase 1 trial of olaparib and oral cyclophosphamide in BRCA breast cancer, recurrent BRCA ovarian cancer, non-BRCA triple-negative breast cancer, and non-BRCA ovarian cancer

por Lee, Chee Khoon, Scott, Clare, Lindeman, Geoffrey J., Hamilton, Anne, Lieschke, Elizabeth, Gibbs, Emma, Asher, Rebecca, Badger, Heath, Paterson, Robin, Macnab, Lauren, Kwan, Edmond Michael, Francis, Prudence A., Boyle, Frances, Friedlander, Michael
Publicado 2019

Nomogram for Estimating Overall Survival in Patients With Metastatic Pancreatic Cancer

por Goldstein, David, Von Hoff, Daniel D., Chiorean, E. Gabriela, Reni, Michele, Tabernero, Josep, Ramanathan, Ramesh K., Botteman, Marc, Aly, Abdalla, Margunato-Debay, Sandra, Lu, Brian, Louis, Chrystal U., McGovern, Desmond, Lee, Chee Khoon
Publicado 2020

A signal-seeking Phase 2 study of olaparib and durvalumab in advanced solid cancers with homologous recombination repair gene alterations

por Thavaneswaran, Subotheni, Kansara, Maya, Lin, Frank, Espinoza, David, Grady, John P., Lee, Chee Khoon, Ballinger, Mandy L., Sebastian, Lucille, Corpuz, Theresa, Qiu, Min Ru, Mundra, Piyushkumar, Bailey, Charles G., Schmitz, Ulf, Simes, John, Joshua, Anthony M., Thomas, David M.
Publicado 2023

Bintrafusp alfa (M7824), a bifunctional fusion protein targeting TGF-β and PD-L1: results from a phase I expansion cohort in patients with recurrent glioblastoma

por Khasraw, Mustafa, Weller, Michael, Lorente, David, Kolibaba, Kathryn, Lee, Chee Khoon, Gedye, Craig, I. de La Fuente, Macarena, Vicente, David, Reardon, David A, Gan, Hui K, Scott, Andrew M, Dussault, Isabelle, Helwig, Christoph, Ojalvo, Laureen S, Gourmelon, Carole, Groves, Morris
Publicado 2021

Sunvozertinib, a Selective EGFR Inhibitor for Previously Treated Non–Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations

por Wang, Mengzhao, Yang, James Chih-Hsin, Mitchell, Paul L., Fang, Jian, Camidge, D. Ross, Nian, Weiqi, Chiu, Chao-Hua, Zhou, Jianying, Zhao, Yanqiu, Su, Wu-Chou, Yang, Tsung-Ying, Zhu, Viola W., Millward, Michael, Fan, Yun, Huang, Wen-Tsung, Cheng, Ying, Jiang, Liyan, Brungs, Daniel, Bazhenova, Lyudmila, Lee, Chee Khoon, Gao, Bo, Xu, Yan, Hsu, Wei-Hsun, Zheng, Li, Jänne, Pasi A.
Publicado 2022

Amivantamab in EGFR Exon 20 Insertion–Mutated Non–Small-Cell Lung Cancer Progressing on Platinum Chemotherapy: Initial Results From the CHRYSALIS Phase I Study

por Park, Keunchil, Haura, Eric B., Leighl, Natasha B., Mitchell, Paul, Shu, Catherine A., Girard, Nicolas, Viteri, Santiago, Han, Ji-Youn, Kim, Sang-We, Lee, Chee Khoon, Sabari, Joshua K., Spira, Alexander I., Yang, Tsung-Ying, Kim, Dong-Wan, Lee, Ki Hyeong, Sanborn, Rachel E., Trigo, José, Goto, Koichi, Lee, Jong-Seok, Yang, James Chih-Hsin, Govindan, Ramaswamy, Bauml, Joshua M., Garrido, Pilar, Krebs, Matthew G., Reckamp, Karen L., Xie, John, Curtin, Joshua C., Haddish-Berhane, Nahor, Roshak, Amy, Millington, Dawn, Lorenzini, Patricia, Thayu, Meena, Knoblauch, Roland E., Cho, Byoung Chul
Publicado 2021